Successful Placement: Muse Bio

Muse bio appoints proven biotech industry executive and innovator, Kevin Ness, as CEO

BOULDER, Colo., Dec. 7, 2016 /PRNewswire/ — Muse bio, a privately-held company leading the development of next-generation genome engineering technologies, today announced that Dr. Kevin Ness has been appointed Chief Executive Officer and member of the Board of Directors. Read the full release